• No results found

Chapter 10: Guidelines in the Play of Governance

10.11 A final reflexive consideration

Você toma ou já tomou bebida alcoólica? ( )Sim ( )Não

Qual o tipo de bebida que você consome ou consumia? ( )Aguardente ( )Uisque ( )Vodca ( )Conhaque ( )Vinho ( )Cerveja ( )Outra Qual?___________________________ Qual a quantidade ingerida por dia?

Número de copos pequenos (100ml)___________________

Número de copos de tamanho normal (200ml)_____________________ Número de garrafas (750ml)___________________________

Outra quantidade? Especifique:________________________________________________

8 REFERÊNCIAS

1. Marques ACPR, Ribeiro M. Projeto Diretrizes. Associação Médica Brasileira e Conselho Federal de Medicina. 2002; 1-20.

2. Witt H. Chronic pancreatitis and cystic fibrosis. Gut 2003; 52:1-25.

3. Buscail L. New insights in idiopathic pancreatitis. Gastroenterol Clin Biol 2003; 27(4):391-3.

4. Mott CB, Guarita DR. Pancreatite Crônica. In: Cordeiro F. (eds).Condutas em Gastroenterologia.São Paulo: Livraria e Editora Revinter Ltda, 2004. 632-4p. 5. Pandol SJ, Raraty M. Pathobiology of alcoholic pancreatitis. Pancreatology

2007; 7:105-114.

6. de Almeida JL, Jukemura J, Sampietre SN, Patzina RA, da Cunha JE, Machado MC. Effect of hypertermia on experimental acute pancreatitis. Arq Gastroenterol 2006; 43(4):316-20.

7. de Almeida JL, Jukemura J, Coelho AM, Patzina RA, Machado MC, da Cunha JE. Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics 2006; 61(4):301-6.

8. Andraus W, Jukemura J, Dutra F, Bechara E, Cunha JE, Leite KR, Machado MC. Oxidative stress is enhanced by hypotermia imposed on cerulein-induced pancreatitis in rats. Clinics 2007; 62(4)483-90.

9. Burton PR, Tobin MD, Hopper JL. Key concepts in genetic epidemiology. Lancet 2005; 366:941-51.

10. Hanck C, Schneider A, Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Best Pract Res Clin Gastroenterol 2003; 17(4):613-23.

11. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-72.

12. Bernardino AL, Guarita DR, Mott CB, Pedroso MRA, Machado MCC, Laudanna AA, Tani CM, Almeida FL, Zatz M. CFTR, PRSS1 and SPINK1 in the development of pancreatitis in brazilian patients. JOP. 2003;4(5):169-177.

13. Cohn JA, Mitchell RM, Jowell PS. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. Gastroenterol Clin N Am 2004; 33:817-21.

14. Bruno MJ. Current insights into the pathogenesis of acute and chronic pancreatitis. Scand J Gastroenterol 2001; 36 Suppl 234:103-108.

15. Whitcomb DC. Value of genetic testing in the management of pancreatitis. Gut 2004;53;1710-1717.

16. Truninger K, Ammann RW, Blum HE, Witt H. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications. Swiss Med Wkly 2001; 131:565-574.

17. Haber PS, Norris MD, Apte MV, Rodgers SC, Norton ID, Pirola RC, Roberts- Thomson IC, Wilson JS. Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystis fibrosis gene. Alcohol Clin Exp Res 1999; 23(3):509-512.

18. Monaghan KG, Jackson CE, Kukuruga DL, Feldman GL. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol related pancreatitis. Am J Med Genet 2000; 94:120-124.

19. Kimura S, Okabayashi Y, Inushima K, Yutsudo Y, Kasuga M. Polymorphism of cystic fibrosis gene in japanese patients with chronic pancreatitis. Dig Dis Sci 2000; 45(10):2007-2012.

20. Casals T, Aparisi L, Costa CM, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farré A. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 2004; 28:374-379.

21. Nakamura Y, Ohmori T, Ishikawa A, Kobayashi Y, Imazeki H, Higuchi S, Maruyama K. Homozygous (TG)11 allele in Intron 8 of the cystic fibrosis transmenbrane conductance regulator (CFTR) gene has a protective role against bicarbonate decrease in pure pancreatic juice among japanese male alcoholics. Intern Med 2004; 43:1131-1137.

22. Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 2003; 11(9):687-92.

23. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339(10):645-652.

24. Truninger K, Malik N, Ammann RW, Muelhaupt B, Seifert B, Müller HJ, Blum HE. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol 2001; 96(9):2658-2661.

25. Gaia E, Salacone P, Gallo M, Promis GG, Brusco A, B C, Carlo A. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002; 47(11):2416-2421.

26. Fujiki K, Ishiguro H, Ko SBH, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S. Genetic evidence for CFTR dysfunction in japanese: background for chronic pancreatitis. J Med Genet 2004; 41(5): e 55.

27. Bhopal RS. Concepts of Epidemiology: an integrated introduction to the ideas, theories, principles, and methods of epidemiology. New York: Oxford University Press; 2002. p.98-133.

28. Engels EA, O’Brien TR. Epidemiological methods for studies of genetic factors that influence infectious diseases. In: Carrington M, Hoelzel AR. Molecular Epidemiology: A Practical Approach. New York: Oxford University Press; 2001. p.01-27.

29. Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR. Medical Epidemiology. 3rd ed. New York: Lange Medical Books; 2001. p.91-140.

30. da Cunha AC, Freddi AJAL, Crestana MF, Aragão MS, Cardoso SC, Vilhena V. Guia de apresentação de dissertações, teses e monografias. 2ª ed. São Paulo: Serviço de Biblioteca e Documentação – SBD/FMUSP; 2005.

31. Whitcomb DC. Genetic predisposition to alcoholic chronic pancreatitis. Pancreas 2003; 27(4):321-326.

32. Cunha RM, Mott CB, Guarita DR, Pedroso MR, Jukemura J, Bacchela T, Cunha JE, Machado MC, Laudanna AA. Complications of chronic pancreatitis in São Paulo (Brazil). Rev Hosp Clin Fac Med Sao Paulo 1997;52(6):306-15.

33. Hill AB. (1965). Proc R Soc Med, volume 58, 295.

34. Lévy P, Barthet M, Mollard BR, Amouretti M, Marion-Audibert AM, Dyard F. Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterol Clin Biol 2006; 30(6-7):838-44.

35. Chen WX, Zhang WF, Li B, Lin HJ, Zhang X, Chen HT, Gu ZY, Li YM. Clinical manifestations of patients with chronic pancreatitis. Hepatobiliary Pancreas Dis Int 2006;5:133-137.

36. Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly 2006; 136:166-174.

37. Vantyghem MC, Moussaïd-Guennoun R, Perimenis P, Marcelli-Tourvieille S, Perez T, Wallaert B. Cystic fibrosis diabetes in adult. Ann Endocrinol (Paris) 2005 Sep;66(4):347-54.

38. Gaia E, Salacone P, Salmin P, Brusco A, Bacillo E e Arduino C. Differences in clinical manifestations in patients with chronic pancreatitis and mutations of CFTR, SPINK1 e PRSS1 genes. JOP 2004; 6(5):521.